Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
Clinical trial NCT04539639 · COMPLETED
Trial details
- NCT number
- NCT04539639
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-05-19
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.